Shandong Lvyin Pharmaceutical Co., Ltd.

The primary study objective was to evaluate the bioequivalence of the test preparation indapamide tablets (2.5 mg/tablet, produced by Shandong Lvyin Pharmaceutical Co., Ltd.) and the reference preparation indapamide tablets (trade name: Natali®, 2.5 mg/tablet, produced by Les Laboratoires Servier) in Chinese healthy adult subjects after single oral administration under fasting conditions. The secondary study objective was to observe the safety of the test preparation indapamide tablets and the reference preparation Natali® in Chinese healthy adult subjects.